Loading...
Header Logo
Keywords
Last Name
Institution

PAUL W WALKER

TitleAssociate Professor
InstitutionMD Anderson
DepartmentPalliative Care & Rehabilitation Medicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Naqash AR, Ricciuti B, Owen DH, Florou V, Toi Y, Cherry C, Hafiz M, De Giglio A, Muzaffar M, Patel SH, Sugawara S, Burkart J, Park W, Chiari R, Sugisaka J, Otterson GA, de Lima Lopes G, Walker PR. Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother. 2020 Apr 28. PMID: 32347358.
      View in: PubMed
    2. Naqash AR, Ricciuti B, Owen DH, Florou V, Toi Y, Cherry C, Hafiz M, De Giglio A, Muzaffar M, Patel SH, Sugawara S, Burkart J, Park W, Chiari R, Sugisaka J, Otterson GA, de Lima Lopes G, Walker PR. Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother. 2020 Mar 05. PMID: 32140762.
      View in: PubMed
    3. Naqash AR, Appah E, Yang LV, Muzaffar M, Marie MA, Mccallen JD, Macherla S, Liles D, Walker PR. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition. J Immunother Cancer. 2019 07 05; 7(1):169. PMID: 31277704.
      View in: PubMed
    4. Naqash AR, Stroud CRG, Butt MU, Dy GK, Hegde A, Muzaffar M, Yang LV, Hafiz M, Cherry CR, Walker PR. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database. Acta Oncol. 2018 06; 57(6):867-872. PMID: 29241410.
      View in: PubMed
    5. Naqash AR, Yang LV, Sanderlin EJ, Atwell DC, Walker PR. Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report. Acta Oncol. 2018 05; 57(5):705-708. PMID: 29171332.
      View in: PubMed
    6. Biswas T, Efird JT, Prasad S, Jindal C, Walker PR. The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer. Oncotarget. 2017 Dec 22; 8(68):112712-112719. PMID: 29348858.
      View in: PubMed
    7. Dutoit V, Migliorini D, Ranzanici G, Marinari E, Widmer V, Lobrinus JA, Momjian S, Costello J, Walker PR, Okada H, Weinschenk T, Herold-Mende C, Dietrich PY. Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma. Oncoimmunology. 2018; 7(2):e1391972. PMID: 29308320.
      View in: PubMed
    8. Hui D, Frisbee-Hume S, Wilson A, Dibaj SS, Nguyen T, De La Cruz M, Walker P, Zhukovsky DS, Delgado-Guay M, Vidal M, Epner D, Reddy A, Tanco K, Williams J, Hall S, Liu D, Hess K, Amin S, Breitbart W, Bruera E. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. JAMA. 2017 09 19; 318(11):1047-1056. PMID: 28975307.
      View in: PubMed
    9. Kalman NS, Weiss E, Walker PR, Rosenman JG. Local Radiotherapy Intensification for Locally Advanced Non-small-cell Lung Cancer - A Call to Arms. Clin Lung Cancer. 2018 01; 19(1):17-26. PMID: 28712978.
      View in: PubMed
    10. Prasad S, Efird JT, James SE, Walker PR, Zagar TM, Biswas T. Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women. Springerplus. 2016; 5(1):756. PMID: 27386241.
      View in: PubMed
    11. Karvinen KH, Vallance J, Walker PR. Newly diagnosed lung cancer patients' preferences for and beliefs about physical activity prior to chemotherapy. Psychol Health Med. 2016 Jul; 21(5):593-600. PMID: 26813963.
      View in: PubMed
    12. Hui D, dos Santos R, Reddy S, Nascimento MS, Zhukovsky DS, Paiva CE, Dalal S, Costa ED, Walker P, Scapulatempo HH, Dev R, Crovador CS, De La Cruz M, Bruera E. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med. 2015 Oct; 29(9):826-33. PMID: 25881622.
      View in: PubMed
    13. Karvinen KH, Esposito D, Raedeke TD, Vick J, Walker PR. Effect of an exercise training intervention with resistance bands on blood cell counts during chemotherapy for lung cancer: a pilot randomized controlled trial. Springerplus. 2014; 3:15. PMID: 24683529.
      View in: PubMed
    14. Zhang J, Gay HA, Russo S, Parent T, Aljumaily R, Walker PR. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer. Lung Cancer. 2014 Jan; 83(1):67-72. PMID: 24246506.
      View in: PubMed
    15. Karvinen KH, McGourty S, Parent T, Walker PR. Physical activity promotion among oncology nurses. Cancer Nurs. 2012 May-Jun; 35(3):E41-8. PMID: 21946904.
      View in: PubMed
    16. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller TP, Palla SL, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhukovsky DS, Reddy S, Elsayem A, Dalal S, Dev R, Walker P, Yennu S, Reddy A, Bruera E. The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist. 2011; 16(11):1642-8. PMID: 21976316.
      View in: PubMed
    17. Quan WD, Gagnon GA, Walker PR, Quan FM. Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer. Cancer Biother Radiopharm. 2011 Feb; 26(1):65-7. PMID: 21348776.
      View in: PubMed
    18. Yennurajalingam S, Dev R, Walker PW, Reddy SK, Bruera E. Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases. J Pain Symptom Manage. 2010 May; 39(5):930-5. PMID: 20471553.
      View in: PubMed
    19. Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, Bruera E. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med. 2010 Jan; 13(1):33-8. PMID: 19824814.
      View in: PubMed
    20. Quan WD, Walker PR, Picton M, Quan FM, King LA, Tyre C, Liles DK. High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. Cancer Biother Radiopharm. 2008 Oct; 23(5):641-6. PMID: 18999936.
      View in: PubMed
    21. Walker PW, Palla S, Pei BL, Kaur G, Zhang K, Hanohano J, Munsell M, Bruera E. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med. 2008 Oct; 11(8):1103-8. PMID: 18980450.
      View in: PubMed
    22. Walker PW, Bruera E, Boohene J. Managing high dose sufentanil in a suffering patient. J Pain Symptom Manage. 2008 Jul; 36(1):e1-4. PMID: 18538537.
      View in: PubMed
    23. Quan WD, Quan FM, King LA, Walker PR. Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. Cancer Biother Radiopharm. 2008 Feb; 23(1):108-13. PMID: 18298334.
      View in: PubMed
    24. Del Fabbro E, Reddy SG, Walker P, Bruera E. Palliative sedation: when the family and consulting service see no alternative. J Palliat Med. 2007 Apr; 10(2):488-92. PMID: 17472523.
      View in: PubMed
    25. Quan WD, Milligan KS, Quan FM, Cuenca RE, Khan N, Liles DK, Walker PR. Continuous infusion interleukin-2 and intravenous famotidine in metastatic melanoma. Cancer Biother Radiopharm. 2006 Dec; 21(6):607-12. PMID: 17257076.
      View in: PubMed
    26. Le Gal FA, Widmer VM, Dutoit V, Rubio-Godoy V, Schrenzel J, Walker PR, Romero PJ, Valmori D, Speiser DE, Dietrich PY. Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors. J Invest Dermatol. 2007 Mar; 127(3):622-9. PMID: 17039243.
      View in: PubMed
    27. Quan WD, Walker PR, Quan FM, Ramirez M, Elsamaloty HM, Ghai V, Vinogradov M, Liles DK. Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2. Cancer Biother Radiopharm. 2006 Oct; 21(5):437-42. PMID: 17105418.
      View in: PubMed
    28. Quan WD, Vinogradov M, Quan FM, Khan N, Liles DK, Walker PR. Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer. Cancer Biother Radiopharm. 2006 Oct; 21(5):515-9. PMID: 17105423.
      View in: PubMed
    29. Walker PR, Khuder SA, Quan WD. Continuous infusion interleukin-2 and antihistamines in metastatic kidney cancer. Cancer Biother Radiopharm. 2005 Oct; 20(5):487-90. PMID: 16248764.
      View in: PubMed
    30. Walker P, Neuhauser MN, Tam VH, Willey JS, Palmer JL, Bruera E, Prince RA. Subcutaneous administration of cefepime. J Pain Symptom Manage. 2005 Aug; 30(2):170-4. PMID: 16125032.
      View in: PubMed
    31. Strasser F, Walker P, Bruera E. Palliative pain management: when both pain and suffering hurt. J Palliat Care. 2005; 21(2):69-79. PMID: 16114805.
      View in: PubMed
    32. Elsayem A, Swint K, Fisch MJ, Palmer JL, Reddy S, Walker P, Zhukovsky D, Knight P, Bruera E. Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol. 2004 May 15; 22(10):2008-14. PMID: 15143094.
      View in: PubMed
    33. Roemer-B├ęcuwe C, Vigano A, Romano F, Neumann C, Hanson J, Quan HK, Walker P. Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration. J Pain Symptom Manage. 2003 Sep; 26(3):843-8. PMID: 12967733.
      View in: PubMed
    34. Walker PW, Klein D, Kasza L. High dose methadone and ventricular arrhythmias: a report of three cases. Pain. 2003 Jun; 103(3):321-4. PMID: 12791438.
      View in: PubMed
    35. Walker P. Management of pressure ulcers. Oncology (Williston Park). 2001 Nov; 15(11):1499-508, 1511; discussion1511,1515-6. PMID: 11758876.
      View in: PubMed
    36. Walker P, Nordell C, Neumann CM, Bruera E. Impact of the Edmonton Labeled Visual Information System on physician recall of metastatic cancer patient histories. a randomized controlled trial. J Pain Symptom Manage. 2001 Jan; 21(1):4-11. PMID: 11223309.
      View in: PubMed
    37. Doyle J, Walker P, Bruera E. Nebulized scopolamine. J Pain Symptom Manage. 2000 May; 19(5):327-8. PMID: 10928852.
      View in: PubMed
    38. Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E. The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer. 1999 Jul; 7(4):265-70. PMID: 10423053.
      View in: PubMed
    39. Walker P, Watanabe S, Bruera E. Baclofen, a treatment for chronic hiccup. J Pain Symptom Manage. 1998 Aug; 16(2):125-32. PMID: 9737104.
      View in: PubMed
    40. Lawlor PG, Watanabe S, Walker P, Bruera E. Re: Memorial Delirium Assessment Scale and commentary. J Pain Symptom Manage. 1998 Feb; 15(2):73-5. PMID: 9494304.
      View in: PubMed
    41. Pereira J, Mancini I, Walker P. The role of bisphosphonates in malignant bone pain: a review. J Palliat Care. 1998; 14(2):25-36. PMID: 9686493.
      View in: PubMed
    42. Walker P, Watanabe S, Lawlor P, Hanson J, Pereira J, Bruera E. Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity. Ann Oncol. 1997 Sep; 8(9):915-6. PMID: 9358945.
      View in: PubMed
    43. Lawlor P, Walker P, Bruera E, Mitchell S. Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence. J Pain Symptom Manage. 1997 Jun; 13(6):356-61. PMID: 9204657.
      View in: PubMed
    44. Walker P, Watanabe S, Taube A. The Edmonton Staging System. J Pain Symptom Manage. 1996 Nov; 12(5):269. PMID: 8942119.
      View in: PubMed
    45. Walker P, Watanabe S, Lawlor P, Bruera E. Subcutaneous clodronate. Lancet. 1996 Aug 03; 348(9023):345-6. PMID: 8709722.
      View in: PubMed
    46. Preface. Hematology/Oncology Clinics of North America. 16.
    WALKER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description